Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
76539663 | 7653966 | 3 | F | 201308 | 20160807 | 20101102 | 20160812 | EXP | PHHY2010CA53417 | NOVARTIS | 50.60 | YR | F | Y | 0.00000 | 20160812 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
76539663 | 7653966 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | U | 21008 | 30 | MG | /month | ||||||
76539663 | 7653966 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK UNK, TID (FOR 17 DAYS) | 0 | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
76539663 | 7653966 | 1 | Acromegaly |
76539663 | 7653966 | 2 | Acromegaly |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
76539663 | 7653966 | OT |
76539663 | 7653966 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
76539663 | 7653966 | Abdominal pain | |
76539663 | 7653966 | Abdominal pain upper | |
76539663 | 7653966 | Arthralgia | |
76539663 | 7653966 | Blood potassium increased | |
76539663 | 7653966 | Blood pressure diastolic increased | |
76539663 | 7653966 | Blood pressure increased | |
76539663 | 7653966 | Blood pressure systolic increased | |
76539663 | 7653966 | Blood urine present | |
76539663 | 7653966 | Bone pain | |
76539663 | 7653966 | Constipation | |
76539663 | 7653966 | Fatigue | |
76539663 | 7653966 | Feeling hot | |
76539663 | 7653966 | Groin pain | |
76539663 | 7653966 | Headache | |
76539663 | 7653966 | Hypersensitivity | |
76539663 | 7653966 | Injection site erythema | |
76539663 | 7653966 | Injection site pruritus | |
76539663 | 7653966 | Injection site rash | |
76539663 | 7653966 | Nausea | |
76539663 | 7653966 | Neck pain | |
76539663 | 7653966 | Pain in extremity | |
76539663 | 7653966 | Peripheral swelling | |
76539663 | 7653966 | Pyrexia | |
76539663 | 7653966 | Swelling face | |
76539663 | 7653966 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
76539663 | 7653966 | 1 | 20100713 | 0 | ||
76539663 | 7653966 | 2 | 20100617 | 201007 | 0 |